In a randomized controlled trial, neurokinin 3 receptor antagonist (NK3Ra) administration in women with PCOS decreased the frequency of LH pulses (indicative of pulsatile GnRH release) and also LH and testosterone concentrations (George et al., 2016). Here, GNRH1 is linked to polycystic ovary syndrome.